SLNO R&D to Revenue
Soleno Therapeutics Inc · R&D to Revenue
SLNO R&D to Revenue
Latest reported21.34%period ending
SLNO FY R&D/Revenue (0.00% → 21.34%)
Latest values, visible window
High-resolution chart · PNG
SLNO r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 21.3371% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -0.1976% | |
| 357.3784% | |
| 1,170.4775% | |
| 0% | |
| 79.3277% | |
| 0% |